Novartis and Gen-Probe Agree to Extend and Expand Blood Screening Collaboration

Companies will work together to protect the world's supply of donated blood from infectious diseases until 2025

30-Jan-2009 - Chiron, a Novartis business, announced that it has agreed to extend and expand its blood screening collaboration with Gen-Probe until 2025. The companies will continue to work together to develop and commercialize molecular technologies that safeguard the world's donated blood supply. The ...

European multi-center study suggests PCA3 test more accurate for prostate cancer

28-Mar-2007 - DiagnoCure announced that preliminary results from an on-going multi-center study presented last week by independent researchers in Europe indicate that a new Gen-Probe PCA3-based test for prostate cancer yielded greater diagnostic accuracy than the free prostate specific antigen (PSA) test on ...

DiagnoCure partner launches new prostate cancer test in Europe

24-Nov-2006 - DiagnoCure announced that its partner, Gen-Probe, has launched a new diagnostic test for prostate cancer in Europe, based on DiagnoCure's PCA3 marker, which clinicians and researchers believe will prove to be much more accurate than current technology. Gen-Probe's PCA3 gene-based test detects ...

Gen-Probe Licenses Technology from AdnaGen That May Increase Accuracy of Molecular Diagnostic Tests for Cancer

Innovative 'Immunocapture' Technology Combined with NAT Also May Help Determine Aggressiveness of Malignancies and Aid in Patient Monitoring

20-Jan-2005 - Gen-Probe has licensed technology from AdnaGen that may help increase the accuracy of molecular diagnostic tests to detect prostate and other cancers, help determine the aggressiveness of these malignancies, and monitor responses to therapy. AdnaGen's proprietary technology enables detection of ...

Gen-Probe Granted Summary Judgment in Enzo Patent Lawsuit

28-Jul-2004 - San Diego. Gen-Probe Incorporated announced that the U.S. District Court for the Southern District of New York has granted summary judgment in Gen-Probe's favor in a patent infringement lawsuit initiated by Enzo Biochem, Inc. The Court ruled that the patent on which Enzo's lawsuit was based ...